Six patients with renal cell carcinoma and four patients with breast cancer were treated with 5 × 107 DCs and 14 consecutive IL-2 injections in a single vaccination protocol, and all patients received two vaccinations at a one-month interval (Figure 1). Here, IL2 is linked to renal cell carcinoma.